Manuscripts
Showing 1554 manuscripts.
Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095
Citation
Jeffrey T. Schouten, Amy Krambrink, Heather Ribaudo, Anne Kmack, Nancy Webb, Cecilia M. Shikuma, Daniel R. Kuritzkes, Roy (Trip) Gulick. Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095. Clinical Infectious Diseases. 2010. 50: 787-91. PMID: 20121419Year
2010
Journal
Clinical Infectious Diseases
HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays
Citation
Sonia Napravnik, Ada Cachafeiro, Paul Stewart, Joseph J. Eron, Susan A. Fiscus. HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays. Journal of Clinical Virology. 2010. 47: 18-22. PMID: 19896416Year
2010
Journal
Journal of Clinical Virology
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial
Citation
John Coffin, John W. Mellors, Rajesh Gandhi, Joseph J. Eron, Lu (Summer) Zheng, Ronald J. Bosch, Ellen Chan, David M. Margolis, Sarah W. Read, Beatrice A. Kallungal, Sarah Palmer, Kathleen A. Medvik, Michael M. Lederman, Nadia Alatrakchi, Jeffrey M. Jacobson, A. Wiegand, Mary Kearney. The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. Public Library of Science: Medicine. 2010. 7: pii: e1000321. PMID: 20711481Year
2010
Journal
Public Library of Science: Medicine
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371
Citation
Carrie Dykes, Lisa Mukherjee, Ronald J. Bosch, Elizabeth Connick, Paul Volberding, Lisa M. Demeter. Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371. Journal of Acquired Immune Deficiency Syndromes. 2010. 55: 132-4. PMID: 20733405Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas
Citation
Cynthia (Cindy) Firnhaber, Laura Smeaton, Nasinuku TJ Saukila, Timothy P. Flanigan, Raman Raghunathrao Gangakhedkar, Jacob M. Kumwenda, Alberto Martin La Rosa, Nagalingeshwaran Kumarasamy, Victor DeGruttola, James Gita Hakim, Thomas B. Campbell. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. International Journal of Infectious Diseases. 2010. 14: e1088-92. PMID: 20961784Year
2010
Journal
International Journal of Infectious Diseases
Possible Mitochondrial Dysfunction and Its Association with Antiretroviral Therapy Use in Children Perinatally Infected with HIV
Citation
Marilyn Jean Crain, Miriam Chernoff, James M. Oleske, Susan Brogly, Kathleen Malee, Peggy R. Borum, William A. Meyer, Wendy G Mitchell, John ( Jack ) Moye, Heather Ford-Chatterton, Russell B. Van Dyke, George Seage. Possible Mitochondrial Dysfunction and Its Association with Antiretroviral Therapy Use in Children Perinatally Infected with HIV. Journal of Infectious Diseases. 2010. 202: 291-301. PMID: 20533872Year
2010
Journal
Journal of Infectious Diseases
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
Citation
Michael T. Brady, James M. Oleske, Paige L. Williams, Carol Elgie, Lynne M. Mofenson, Wayne M. Dankner, Russell B. Van Dyke. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.. Journal of Acquired Immune Deficiency Syndromes. 2010. 53: 86-94. PMID: 20035164Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines
Citation
Adriana Weinberg, Lin-Ye Song, Robert Walker, Maria Allende, Terence Fenton, Sharon Appelbaum Nachman, Jennifer S. Read, Julie A. Patterson, Myron Levin. T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines. AIDS Research and Human Retroviruses. 2010. 26: 51-9. PMID: 20059397Year
2010
Journal
AIDS Research and Human Retroviruses
Study
P1057
Safety and Immunogenicity of a Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Vaccine in HIV-Infected Children 7 TO 12 Years Old
Citation
Myron Levin, Anna-Barbara Moscicki, Lin-Ye Song, Terence Fenton, Emily Demske, William A. Meyer, Barbara Nowak, Carlos A. Sattler, Alfred J. Saah, David Radley, Mark T. Esser, Adriana Weinberg. Safety and Immunogenicity of a Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Vaccine in HIV-Infected Children 7 TO 12 Years Old. Journal of Acquired Immune Deficiency Syndromes. 2010. 55: 197-204. PMID: 20574412Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1047
Directly Observed Therapy (DOT) for Non-adherent HIV Infected Youth - Lessons Learned, Challenges Ahead
Citation
Aditya Gaur, Marvin Eric Belzer, Paula Britto, Patricia A. Garvie, ChengCheng Hu, Bobbie L. Graham, Michael N. Neely, George D. McSherry, Stephen A. Spector, Patricia M. Flynn. Directly Observed Therapy (DOT) for Non-adherent HIV Infected Youth - Lessons Learned, Challenges Ahead. AIDS Research and Human Retroviruses. 2010. 26: 947-53. PMID: 20707731Year
2010
Journal
AIDS Research and Human Retroviruses
Study
P1036B